These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 17107793)
1. Evaluating scoring functions for docking and designing beta-secretase inhibitors. Katharine Holloway M; McGaughey GB; Coburn CA; Stachel SJ; Jones KG; Stanton EL; Gregro AR; Lai MT; Crouthamel MC; Pietrak BL; Munshi SK Bioorg Med Chem Lett; 2007 Feb; 17(3):823-7. PubMed ID: 17107793 [TBL] [Abstract][Full Text] [Related]
2. Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind beta-secretase in a N-terminal 10s-loop down conformation. Stauffer SR; Stanton MG; Gregro AR; Steinbeiser MA; Shaffer JR; Nantermet PG; Barrow JC; Rittle KE; Collusi D; Espeseth AS; Lai MT; Pietrak BL; Holloway MK; McGaughey GB; Munshi SK; Hochman JH; Simon AJ; Selnick HG; Graham SL; Vacca JP Bioorg Med Chem Lett; 2007 Mar; 17(6):1788-92. PubMed ID: 17257835 [TBL] [Abstract][Full Text] [Related]
3. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors. Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700 [TBL] [Abstract][Full Text] [Related]
4. Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation. Zhu Z; Sun ZY; Ye Y; Voigt J; Strickland C; Smith EM; Cumming J; Wang L; Wong J; Wang YS; Wyss DF; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Parker E; McKittrick BA; Stamford A; Czarniecki M; Greenlee W; Hunter JC J Med Chem; 2010 Feb; 53(3):951-65. PubMed ID: 20043696 [TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel warhead against beta-secretase through fragment-based lead generation. Geschwindner S; Olsson LL; Albert JS; Deinum J; Edwards PD; de Beer T; Folmer RH J Med Chem; 2007 Nov; 50(24):5903-11. PubMed ID: 17985861 [TBL] [Abstract][Full Text] [Related]
6. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening. Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048 [TBL] [Abstract][Full Text] [Related]
7. Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase. Congreve M; Aharony D; Albert J; Callaghan O; Campbell J; Carr RA; Chessari G; Cowan S; Edwards PD; Frederickson M; McMenamin R; Murray CW; Patel S; Wallis N J Med Chem; 2007 Mar; 50(6):1124-32. PubMed ID: 17315857 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR of bis-statine based peptides as BACE 1 inhibitors. Hu B; Fan KY; Bridges K; Chopra R; Lovering F; Cole D; Zhou P; Ellingboe J; Jin G; Cowling R; Bard J Bioorg Med Chem Lett; 2004 Jul; 14(13):3457-60. PubMed ID: 15177452 [TBL] [Abstract][Full Text] [Related]
9. Molecular docking and structure-activity relationship studies on benzothiazole based non-peptidic BACE-1 inhibitors. Xu W; Chen G; Zhu W; Zuo Z Bioorg Med Chem Lett; 2010 Nov; 20(21):6203-7. PubMed ID: 20850315 [TBL] [Abstract][Full Text] [Related]
10. Application of fragment screening by X-ray crystallography to beta-secretase. Murray CW; Callaghan O; Chessari G; Cleasby A; Congreve M; Frederickson M; Hartshorn MJ; McMenamin R; Patel S; Wallis N J Med Chem; 2007 Mar; 50(6):1116-23. PubMed ID: 17315856 [TBL] [Abstract][Full Text] [Related]
11. Fragment-based discovery of BACE1 inhibitors using functional assays. Godemann R; Madden J; Krämer J; Smith M; Fritz U; Hesterkamp T; Barker J; Höppner S; Hallett D; Cesura A; Ebneth A; Kemp J Biochemistry; 2009 Nov; 48(45):10743-51. PubMed ID: 19799414 [TBL] [Abstract][Full Text] [Related]
12. Structure-based design and synthesis of novel P2/P3 modified, non-peptidic beta-secretase (BACE-1) inhibitors. Hanessian S; Shao Z; Betschart C; Rondeau JM; Neumann U; Tintelnot-Blomley M Bioorg Med Chem Lett; 2010 Mar; 20(6):1924-7. PubMed ID: 20172717 [TBL] [Abstract][Full Text] [Related]
13. Novel non-peptide beta-secretase inhibitors derived from structure-based virtual screening and bioassay. Xu W; Chen G; Liew OW; Zuo Z; Jiang H; Zhu W Bioorg Med Chem Lett; 2009 Jun; 19(12):3188-92. PubMed ID: 19447035 [TBL] [Abstract][Full Text] [Related]
14. Self-organizing molecular field analysis on human β-secretase nonpeptide inhibitors: 5, 5-disubstituted aminohydantoins. Li Z; Zhou M; Wu F; Li R; Ding Z Eur J Med Chem; 2011 Jan; 46(1):58-64. PubMed ID: 21093114 [TBL] [Abstract][Full Text] [Related]